Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Naapbooks Ltd
Industry : Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value(
)
543351
INE0GOA01018
16.800816
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
N.A
84.57
53.4
EPS(TTM)
Face Value(
)
Div & Yield %:
0.7
10
0
Back
Kabra Drugs Ltd
Kabra Drugs Ltd - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday I.E. January 23 2024.
Jan 18,2024
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 inter alia to consider and approve We are pleased to inform you that the meeting of the Board of Directors of KABRA DRUGS LIMITED is scheduled to be held on Tuesday i.e. January 23 2024 at the Registered office of the Company situated at Shop No. 270 Shastri Market Indore Madhya Pradesh 452001 India. inter alia to consider and approve the following matters: To consider and approve proposal of fund raising by issue of equity shares or any other permitted mode through Preferential Allotment/Private Placement basis to the Non-Promoter / Public Category of investors in accordance with the provision of the Companies Act 2013 and SEBI (Issue of Capital and Disclosure Requirements Regulation 2018 as amended subject to regulatory or statutory approvals as may be required including the approval of the shareholders of the Company. Increase in Authorised Share Capital of the company from Rs.5 crores to Rs.16 Crores. Any other matter with permission of the Chairman.